Skip to Content
Merck
  • Effects of combination therapy with levamlodipine and bisoprolol on stroke in rats.

Effects of combination therapy with levamlodipine and bisoprolol on stroke in rats.

CNS neuroscience & therapeutics (2013-02-28)
Huan Gui, Yong-Fei Guo, Xia Liu, Jing-Ming Zhang, Yan-Ling Yang, Gao-Zhong Huang, Jian-Guo Liu
ABSTRACT

To examine the effects of combination with levamlodipine and bisoprolol on stroke in rats. For acute study, Systolic blood pressure (SBP) and heart period (HP) were monitored in conscious stroke prone-spontaneously hypertensive rats (SHR-SP) and sinoaortic denervation (SAD) rats before and after intragastric administration of either drug at a single dose. Rats were subjected to middle cerebral arterial occlusion (MCAO) half an hour after drug administration; sacrificed 24 h later to measure the infarct size. For long-term study, drugs (either alone or in combination) were delivered via food to SHR-SP. The survival time was recorded. SBP was significantly reduced by combination therapy both in SHR-SP and SAD rats. Neutralization on heart rate (HR) was observed in combination. The drug combination increased baroreflex sensitivity (BRS) and reduced SBP variability (SBPV). In chronic experiments, the lifespan of SHR-SP rats exposed to the drug combination was longer than that in rats exposed to either drug alone. The infarct area was the smallest in subjects receiving drug combination in SD rats both with and without SAD. Combined use of levamlodipine and bisoprolol produced better protection against stroke.

MATERIALS
Product Number
Brand
Product Description

Supelco
Nicotinic acid, analytical standard
Sigma-Aldrich
Nicotinic acid, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinic acid, ≥98%
Sigma-Aldrich
Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Nicotinic acid, meets USP testing specifications
Sigma-Aldrich
Nicotinic acid sodium salt, 98%
Sigma-Aldrich
Bisoprolol hemifumarate salt, ≥98% (HPLC), solid
Supelco
Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material
Bisoprolol for peak identification, European Pharmacopoeia (EP) Reference Standard
Bisoprolol fumarate, European Pharmacopoeia (EP) Reference Standard
Bisoprolol for system suitability, European Pharmacopoeia (EP) Reference Standard